Results of Placing in Oncopeptides AB
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA. PRESS RELEASE 16 August 2018 Sale of 1,200,000 existing shares in Oncopeptides by Industrifonden Further to the announcement by Stiftelsen Industrifonden ("Industrifonden"), on 15 August 2018, Industrifondenannounces it has sold 1,200,000 existing shares in Oncopeptides AB (publ) ("Oncopeptides" or the "Company"), equivalent to approximately 2.73% of the existing share capital and voting rights in Oncopeptides, to institutional investors pursuant to an